Loading...
Loading...
India's spironolactone imports from UNITED STATES total $22.1K across 20 shipments from 15 foreign suppliers. APTEKA RX INC. (AMSTERDAM PHARMA) leads with $6.5K in import value; the top 5 suppliers together control 82.7% of this origin. Leading Indian buyers include CALLIDUS RESEARCH LABORATORIES PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for spironolactone — a diversified sourcing base with multiple active suppliers from UNITED STATES.

APTEKA RX INC. (AMSTERDAM PHARMA) is the leading Spironolactone supplier from UNITED STATES to India, with import value of $6.5K across 1 shipments. The top 5 suppliers — APTEKA RX INC. (AMSTERDAM PHARMA), M/S REGIONAL PHARMACY, AMSTERDAM PHARMA (APTEKA RX INC), RAFF & HALL PHARMACY,, M/S RAFF & HALL PHARMACY — collectively account for 82.7% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | APTEKA RX INC. (AMSTERDAM PHARMA) | $6.5K | 1 | 29.2% |
| 2 | M/S REGIONAL PHARMACY | $4.6K | 2 | 20.8% |
| 3 | AMSTERDAM PHARMA (APTEKA RX INC) | $3.7K | 2 | 16.8% |
| 4 | RAFF & HALL PHARMACY, | $2.4K | 1 | 11.0% |
| 5 | M/S RAFF & HALL PHARMACY | $1.1K | 2 | 4.9% |
| 6 | AGRACE PHARMA | $978 | 1 | 4.4% |
| 7 | GOOD HEALTH PHARMA SUPPLIES | $795 | 1 | 3.6% |
| 8 | NEWLIFE MEDICALS (USA).INC. | $671 | 1 | 3.0% |
| 9 | Good Health Pharma Supplies | $582 | 1 | 2.6% |
| 10 | MS NEW LIFE MEDICALS (USA) INC | $432 | 1 | 2.0% |
| 11 | Spring Bio Solution | $250 | 1 | 1.1% |
| 12 | REGIONAL PHARMACY | $79 | 1 | 0.4% |
| 13 | ZYDUS HEALTHCARE (USA) LLC | $35 | 2 | 0.2% |
| 14 | AMSTERDAM PHARMA | $10 | 1 | 0.0% |
| 15 | SARFEZ PHARMACEUTICALS INC | $3 | 1 | 0.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | CALLIDUS RESEARCH LABORATORIES PRIVATE LIMITED | $6.5K | 1 | 29.2% |
| 2 | JUBILANT GENERICS LIMITED | $3.7K | 2 | 16.8% |
| 3 | GRAVITI PHARMACEUTICALS PRIVATE LIMITED | $3.0K | 3 | 13.4% |
| 4 | QPS BIOSERVE INDIA PRIVATE LIMITED | $2.7K | 1 | 12.4% |
| 5 | ZYDUS LIFESCIENCES LIMITED | $2.4K | 2 | 11.0% |
| 6 | HETERO LABS LIMITED | $2.4K | 3 | 10.6% |
| 7 | WINDLAS BIOTECH LIMITED | $671 | 1 | 3.0% |
| 8 | RUBICON RESEARCH PRIVATE LIMITED | $432 | 1 | 2.0% |
| 9 | HETERO LABS LIMITED | $250 | 1 | 1.1% |
| 10 | ENEM NOSTRUM REMEDIES PRIVATE LIMITED | $79 | 1 | 0.4% |
| 11 | CADILA HEALTHCARE LIMITED | $31 | 1 | 0.1% |
| 12 | CIPLA LIMITED | $10 | 1 | 0.0% |
| 13 | SYNGENE INTERNATIONAL LIMITED | $3 | 1 | 0.0% |
| 14 | NOVITIUM LABS PRIVATE LIMITED | $0 | 1 | 0.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Spironolactone suppliers from UNITED STATES to India include APTEKA RX INC. (AMSTERDAM PHARMA), M/S REGIONAL PHARMACY, AMSTERDAM PHARMA (APTEKA RX INC). The leading supplier is APTEKA RX INC. (AMSTERDAM PHARMA) with import value of $6.5K USD across 1 shipments. India imported Spironolactone worth $22.1K USD from UNITED STATES in total across 20 shipments.
India imported Spironolactone worth $22.1K USD from UNITED STATES across 20 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Spironolactone sourced from UNITED STATES include CALLIDUS RESEARCH LABORATORIES PRIVATE LIMITED, JUBILANT GENERICS LIMITED, GRAVITI PHARMACEUTICALS PRIVATE LIMITED. The largest buyer is CALLIDUS RESEARCH LABORATORIES PRIVATE LIMITED with $6.5K in imports across 1 shipments.
The total value of Spironolactone imports from UNITED STATES to India is $22.1K USD, across 20 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
20 Verified Shipments
15 suppliers, 14 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists